Safinamide as an Adjunct to Levodopa in Asian and Caucasian Patients With Parkinson’s Disease and Motor Fluctuations: A Post Hoc Analysis of the SETTLE Study

OBJECTIVE: Safinamide is a selective, reversible monoamine oxidase B inhibitor with demonstrated efficacy and tolerability in placebo-controlled studies and is clinically useful for patients with motor fluctuations. This study evaluated the efficacy and safety of safinamide as a levodopa adjunct the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhidayasiri, Roongroj, Ishida, Takayuki, Kamei, Takanori, Husni, Ryan Edbert, Suzuki, Ippei, Wu, Shey Lin, Cho, Jin Whan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Movement Disorder Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236023/
https://www.ncbi.nlm.nih.gov/pubmed/37096301
http://dx.doi.org/10.14802/jmd.22196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236023/
https://www.ncbi.nlm.nih.gov/pubmed/37096301
http://dx.doi.org/10.14802/jmd.22196

Ejemplares similares